JAMA Study Finds Robotic Cystectomy Survival Rates Better Than Open
Date : May 27, 2022
In a report published on May 15, 2022, a team of UK researchers led by James W. F. Catto, PhD release their findings of a random clinical trial of over 300 patients with nonmetastastic bladder cancer. The patients were recruited from 2017 to 2020, with follow up studies at 90 days, 6 months and 12 months. About half received open radical cystectomies, the rest were treated robotically. The final follow-up was in September, 2021. The robotic patients fared better than the open patients in this study.
From the Abstract:
Conclusions and Relevance: Among patients with nonmetastatic bladder cancer undergoing radical cystectomy, treatment with robot-assisted radical cystectomy with intracorporeal urinary diversion vs open radical cystectomy resulted in a statistically significant increase in days alive and out of the hospital over 90 days. However, the clinical importance of these findings remains uncertain.